National, Phase II Study Designed to Evaluate the Safety and Efficacy of Paraplatin in Combination With Taxol in Patients of 70 Years and Older With Ovary Cancer F.I.G.O. Stages III and IV. FAG-2
Phase of Trial: Phase II
Latest Information Update: 05 Jun 2009
At a glance
- Drugs Paclitaxel (Primary) ; Carboplatin
- Indications Ovarian cancer
- Focus Therapeutic Use
- 05 Jun 2009 New trial record.